Schuetz E G, Schmid W, Schutz G, Brimer C, Yasuda K, Kamataki T, Bornheim L, Myles K, Cole T J
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Drug Metab Dispos. 2000 Mar;28(3):268-78.
Cytochrome P-4503A, CYP2B, and P-450 reductase are induced by glucocorticoids, antiglucocorticoids such as pregnenolone 16alpha-carbonitrile, and drugs such as rifampin and phenobarbital. Although the pregnane X receptor is reported to mediate steroid and drug activation of CYP3A via a conserved cis-element in CYP3A genes, discrepancies exist between the induction of the endogenous CYP3A genes and the activation of the pregnane X receptor. It is a formal possibility that the glucocorticoid receptor may account for some of these discrepancies. To determine the requirement in vivo of the glucocorticoid receptor in expression of CYP3A and CYP2B, we compared the induction of these proteins in the livers of normal mice and mice with a targeted mutation in the glucocorticoid receptor. Mice lacking the glucocorticoid receptor show no difference in constitutive hepatic expression of CYP3A but show a decrease in the level of CYP2B. Glucocorticoid receptor-deficient mice challenged with either dexamethasone or pregnenolone 16alpha-carbonitrile failed to induce CYP2B proteins, whereas CYP2B was readily induced in (+/+) mice. In contrast, CYP3A and P-450 reductase proteins were induced by either inducer in wild-type and glucocorticoid receptor-null mice. Similarly, rifampin induced CYP3A in either wild-type or glucocorticoid receptor-null mice. Despite reports that rifampin is a nonsteroidal ligand for the human glucocorticoid receptor, rifampin failed to induce tyrosine aminotransferase in mice regardless of glucocorticoid receptor genotype, and rifampin did not compete for ligand binding to either mouse or human glucocorticoid receptor. Phenobarbital induced CYP3A, CYP2B, and P-450 reductase in all mice, but the amplitude of induction was diminished 37% in glucocorticoid receptor-null mice. Thus, there are distinctly different essential requirements of CYP3A, CYP2B, and P-450 reductase genes for the glucocorticoid receptor in their induction by steroids and drugs.
细胞色素P-4503A、CYP2B和P-450还原酶可被糖皮质激素、抗糖皮质激素(如孕烯醇酮16α-腈)以及利福平、苯巴比妥等药物诱导。尽管据报道孕烷X受体通过CYP3A基因中的保守顺式元件介导CYP3A的类固醇和药物激活,但内源性CYP3A基因的诱导与孕烷X受体的激活之间存在差异。糖皮质激素受体可能是造成其中一些差异的原因,这是一种形式上的可能性。为了确定体内糖皮质激素受体对CYP3A和CYP2B表达的需求,我们比较了正常小鼠和糖皮质激素受体发生靶向突变的小鼠肝脏中这些蛋白质的诱导情况。缺乏糖皮质激素受体的小鼠在CYP3A的组成性肝脏表达上没有差异,但CYP2B水平有所降低。用 dexamethasone或孕烯醇酮16α-腈攻击的糖皮质激素受体缺陷小鼠未能诱导CYP2B蛋白,而在(+/+)小鼠中CYP2B很容易被诱导。相比之下,野生型和糖皮质激素受体缺失小鼠中的任何一种诱导剂都能诱导CYP3A和P-450还原酶蛋白。同样,利福平在野生型或糖皮质激素受体缺失小鼠中均能诱导CYP3A。尽管有报道称利福平是人类糖皮质激素受体的非甾体配体,但无论糖皮质激素受体基因型如何,利福平都不能在小鼠中诱导酪氨酸转氨酶,并且利福平不会竞争与小鼠或人类糖皮质激素受体的配体结合。苯巴比妥在所有小鼠中均能诱导CYP3A、CYP2B和P-450还原酶,但在糖皮质激素受体缺失小鼠中诱导幅度降低了37%。因此,在类固醇和药物诱导过程中,CYP3A、CYP2B和P-450还原酶基因对糖皮质激素受体有明显不同的基本需求。